低深度全基因组测序用于产前诊断的验证
本研究在产前实验室比较低深度全基因组测序(LP-GS)10倍与5倍平均深度与染色体微阵列(CMA)在检测拷贝数变异和杂合性缺失上的一致性、敏感性、特异性、流程效率与成本效益。结果显示LP-GS与CMA高度一致,且10倍深度成本中性、5倍深度成本更优,流程效率提高。作者认为LP-GS是产前诊断中CMA有前景的替代方案。
要点
- LP-GS与CMA在检测拷贝数变异和杂合性缺失上高度一致。
- 与CMA相比,LP-GS提高了流程效率,10倍深度成本中性,5倍深度成本更优。
- LP-GS可为已开展二代测序的实验室提供统一平台,整合工作流程。
核心结论
- LP-GS是产前诊断中CMA有前景的替代方案,具有更高效的流程和适用于更大检测量的可扩展性。
- 对于已单独采用二代测序的临床实验室,LP-GS便于形成以二代测序为中心的统一方法并整合工作流程。
研究设计与样本
- 在产前实验室比较LP-GS 10倍与5倍平均深度与CMA的检测表现。
主要发现
- LP-GS与CMA在检测拷贝数变异和杂合性缺失上高度一致。
- 与CMA相比,LP-GS提高了流程效率,10倍深度成本中性,5倍深度成本更优。
临床怎么用
- 作者认为LP-GS是产前诊断中CMA有前景的替代方案,可提供更高效的流程并适用于更大检测量。
- 作者认为对于已单独采用二代测序的临床实验室,LP-GS便于形成以二代测序为中心的统一方法并整合工作流程。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Chromosomal microarray (CMA), while considered the gold standard for detecting copy number variants (CNVs) in prenatal diagnostics, has its limitations, including the necessity to replace aging microarray equipment, low throughput, a static design, and an inefficient multi-day workflow. This study evaluates the feasibility of low-pass genome sequencing (LP-GS) as a potential replacement for CMA in prenatal diagnostics. METHODS: We comprehensively compared LP-GS at 10x and 5x average depths with CMA in a prenatal laboratory. We examined parameters, including concordance, sensitivity, specificity, workflow efficiency, and cost-effectiveness. RESULTS: We found a high degree of agreement between LP-GS and CMA for detecting CNVs and absence of heterozygosity. Furthermore, compared to CMA, LP-GS increased workflow efficiency and proved to be cost-neutral at 10x and cost-effective at 5x. CONCLUSION: Our study suggests that LP-GS is a promising alternative to CMA in prenatal diagnostics, offering advantages, including a more efficient workflow and scalability for larger testing volumes. Importantly, for clinical laboratories that have adopted next-generation sequencing in a separate capacity, LP-GS facilitates a unified NGS-centric approach, enabling workflow consolidation. By offering a single, streamlined platform for detecting a broad range of genetic variants, LP-GS may represent a critical step toward enhancing the diagnostic capabilities of prenatal laboratories.
引用
- Mighton C, Noor A, Watkins N, et al. Validation of low-pass genome sequencing for prenatal diagnosis. Prenat Diagn. 2024. PMID: 38279846. doi:10.1002/pd.6525
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。